Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma
Publication information:
Potter D, Du R, Bohl S, Chow KH, Ligon K, Bueno R, Letai. Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma.
Nat Commun. 2023;14(2897).